Showing 1 - 10 of 136
This study seeks to provide evidence for deciding whether or not a pharmaceutical innovation should be included in the benefit list of social health insurance. A discrete choice experiment (DCE) was conducted in Germany to measure preferences for modern insulin therapy. Of the 1,100 individuals...
Persistent link: https://www.econbiz.de/10003900791
; Innovation ; Pharmaceuticals ; Health care expenditure ; Cointegration …
Persistent link: https://www.econbiz.de/10003900852
Persistent link: https://www.econbiz.de/10012632073
This study investigates the effectiveness of dynamic norm nudges in promoting second-dose HPV vaccinations among trendsetters-parents who initiated the firstdose HPV vaccine for their daughters between 2017-2020. Utilizing administrative data from Bogota's Secretariat of Health in a field...
Persistent link: https://www.econbiz.de/10014540586
Persistent link: https://www.econbiz.de/10013407493
Persistent link: https://www.econbiz.de/10009304466
Persistent link: https://www.econbiz.de/10014335697
With the ongoing trade normalisation process between India and Pakistan, opportunities to integrate have opened up between both countries. The pharmaceutical sector is crucial to health issues in developing economies and would be an ideal segment to focus on in improving trade relations between...
Persistent link: https://www.econbiz.de/10010404687
Persistent link: https://www.econbiz.de/10009574196
Persistent link: https://www.econbiz.de/10014556631